Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

The impact of meeting locations for men having sex with men on the risk for bacterial sexually transmitted infections: analyses from a cross-sectional online survey.

Marcus U, an der Heiden M, Gassowski M, Kruspe M, Drewes J.

BMJ Open. 2015 Nov 4;5(11):e009107. doi: 10.1136/bmjopen-2015-009107.

2.

Determinants of HIV, viral hepatitis and STI prevention needs among African migrants in Germany; a cross-sectional survey on knowledge, attitudes, behaviors and practices.

Santos-Hövener C, Marcus U, Koschollek C, Oudini H, Wiebe M, Ouedraogo OI, Thorlie A, Bremer V, Hamouda O, Dierks ML, An der Heiden M, Krause G.

BMC Public Health. 2015 Aug 6;15:753. doi: 10.1186/s12889-015-2098-2.

3.

From pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany.

Schmidt D, Kollan C, Stoll M, Stellbrink HJ, Plettenberg A, Fätkenheuer G, Bergmann F, Bogner JR, van Lunzen J, Rockstroh J, Esser S, Jensen BE, Horst HA, Fritzsche C, Kühne A, an der Heiden M, Hamouda O, Bartmeyer B; ClinSurv Study Group.

BMC Public Health. 2015 Mar 17;15:252. doi: 10.1186/s12889-015-1598-4.

4.

Ebola response missions: to go or not to go? Cross-sectional study on the motivation of European public health experts, December 2014.

Rexroth U, Diercke M, Peron E, Winter C, an der Heiden M, Gilsdorf A.

Euro Surveill. 2015 Mar 26;20(12). pii: 21070.

5.

Estimating the residual risk for HIV, HCV and HBV in different types of platelet concentrates in Germany.

an der Heiden M, Ritter S, Hamouda O, Offergeld R.

Vox Sang. 2015 Feb;108(2):123-30. doi: 10.1111/vox.12204. Epub 2014 Oct 21.

PMID:
25335096
6.

Bayesian nowcasting during the STEC O104:H4 outbreak in Germany, 2011.

Höhle M, an der Heiden M.

Biometrics. 2014 Dec;70(4):993-1002. doi: 10.1111/biom.12194. Epub 2014 Jun 13.

PMID:
24930473
7.

Internet-based syndromic monitoring of acute respiratory illness in the general population of Germany, weeks 35/2011 to 34/2012.

Bayer C, Remschmidt C, an der Heiden M, Tolksdorf K, Herzhoff M, Kaersten S, Buda S, Haas W, Buchholz U.

Euro Surveill. 2014 Jan 30;19(4). pii: 20684. No abstract available.

8.

HIV-prevalence in tuberculosis patients in Germany, 2002-2009: an estimation based on HIV and tuberculosis surveillance data.

Fiebig L, Kollan C, Hauer B, Gunsenheimer-Bartmeyer B, An der Heiden M, Hamouda O, Haas W.

PLoS One. 2012;7(11):e49111. doi: 10.1371/journal.pone.0049111. Epub 2012 Nov 7.

9.

Impact of rotavirus vaccination in regions with low and moderate vaccine uptake in Germany.

Dudareva-Vizule S, Koch J, An der Heiden M, Oberle D, Keller-Stanislawski B, Wichmann O.

Hum Vaccin Immunother. 2012 Oct;8(10):1407-15. doi: 10.4161/hv.21593. Epub 2012 Sep 7.

10.

Preventable and non-preventable risk factors for influenza transmission and hygiene behavior in German influenza households, pandemic season (H1N1) 2009/2010.

Remschmidt C, Stöcker P, an der Heiden M, Suess T, Luchtenberg M, Schink SB, Schweiger B, Haas W, Buchholz U.

Influenza Other Respir Viruses. 2013 May;7(3):418-25. doi: 10.1111/j.1750-2659.2012.00407.x. Epub 2012 Jul 16.

11.

The risk of AIDS-defining events is decreasing over time in the German HIV-1 Seroconverter Cohort.

Altmann M, An der Heiden M, Scheufele R, Hartmann K, Houareau C, Bartmeyer B, Hamouda O; German HIV-1 Seroconverter Cohort.

BMC Infect Dis. 2012 Apr 19;12:94. doi: 10.1186/1471-2334-12-94.

12.

Late presentation for HIV diagnosis and care in Germany.

Zoufaly A, an der Heiden M, Marcus U, Hoffmann C, Stellbrink H, Voss L, van Lunzen J, Hamouda O; ClinSurv Study Group.

HIV Med. 2012 Mar;13(3):172-81. doi: 10.1111/j.1468-1293.2011.00958.x. Epub 2011 Nov 7.

13.

German outbreak of Escherichia coli O104:H4 associated with sprouts.

Buchholz U, Bernard H, Werber D, Böhmer MM, Remschmidt C, Wilking H, Deleré Y, an der Heiden M, Adlhoch C, Dreesman J, Ehlers J, Ethelberg S, Faber M, Frank C, Fricke G, Greiner M, Höhle M, Ivarsson S, Jark U, Kirchner M, Koch J, Krause G, Luber P, Rosner B, Stark K, Kühne M.

N Engl J Med. 2011 Nov 10;365(19):1763-70. doi: 10.1056/NEJMoa1106482. Epub 2011 Oct 26.

14.

Timeliness of surveillance during outbreak of Shiga Toxin-producing Escherichia coli infection, Germany, 2011.

Altmann M, Spode A, Altmann D, Wadl M, Benzler J, Eckmanns T, Krause G, An der Heiden M.

Emerg Infect Dis. 2011 Oct;17(10):1906-9. doi: 10.3201/eid1710.111027.

15.

Effectiveness of the AS03-adjuvanted vaccine against pandemic influenza virus A/(H1N1) 2009--a comparison of two methods; Germany, 2009/10.

Uphoff H, An der Heiden M, Schweiger B, Campe H, Beier D, Helmeke C, Littmann M, Haas W, Buda S, Faensen D, Feig M, Altmann D, Wichmann O, Eckmanns T, Buchholz U.

PLoS One. 2011;6(7):e19932. doi: 10.1371/journal.pone.0019932. Epub 2011 Jul 18.

16.

A large outbreak of influenza B-associated benign acute childhood myositis in Germany, 2007/2008.

Mall S, Buchholz U, Tibussek D, Jurke A, An der Heiden M, Diedrich S, Schweiger B, Alpers K.

Pediatr Infect Dis J. 2011 Aug;30(8):e142-6. doi: 10.1097/INF.0b013e318217e356.

PMID:
21753259
17.

Enhanced surveillance during a large outbreak of bloody diarrhoea and haemolytic uraemic syndrome caused by Shiga toxin/verotoxin-producing Escherichia coli in Germany, May to June 2011.

Wadl M, Rieck T, Nachtnebel M, Greutélaers B, an der Heiden M, Altmann D, Hellenbrand W, Faber M, Frank C, Schweickert B, Krause G, Benzler J, Eckmanns T; HUS surveillance and laboratory team.

Euro Surveill. 2011 Jun 16;16(24). pii: 19893.

18.

Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany.

Frank C, Werber D, Cramer JP, Askar M, Faber M, an der Heiden M, Bernard H, Fruth A, Prager R, Spode A, Wadl M, Zoufaly A, Jordan S, Kemper MJ, Follin P, Müller L, King LA, Rosner B, Buchholz U, Stark K, Krause G; HUS Investigation Team.

N Engl J Med. 2011 Nov 10;365(19):1771-80. doi: 10.1056/NEJMoa1106483. Epub 2011 Jun 22.

19.

Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany--a case-control study.

Schmidt AJ, Rockstroh JK, Vogel M, An der Heiden M, Baillot A, Krznaric I, Radun D.

PLoS One. 2011 Mar 8;6(3):e17781. doi: 10.1371/journal.pone.0017781.

20.

Clinical outcome of HIV-infected patients with discordant virological and immunological response to antiretroviral therapy.

Zoufaly A, an der Heiden M, Kollan C, Bogner JR, Fätkenheuer G, Wasmuth JC, Stoll M, Hamouda O, van Lunzen J; ClinSurv Study Group.

J Infect Dis. 2011 Feb 1;203(3):364-71. doi: 10.1093/jinfdis/jiq055. Epub 2010 Dec 8.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk